Company: XERI
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001477932-25-008494
Chunk: 72

Company: XERIANT, INC.
Filing Date: 2025-11-19
Form: 10-Q
Item: Part I, Item 1
Chunk 72
---
 profits may be limited under the provisions of Internal Revenue Code Section 381 upon any future change(s) in control of the Company.

NOTE 12 – SUBSEQUENT EVENTS Stock Issuances  On October 1, 2025, the Company issued 2,200,000 common shares that were converted from a convertible note with a principal amount of $20,000 and accrued interest of $2,000. On October 29, 2025, the Company issued 2,750,000 common shares that were converted from a convertible note with a principal amount of $25,000 and accrued interest of $2,500. On November 4, 2025, the Company issued 4,400,000 common shares that were converted from a convertible note with a principal amount of $40,000 and accrued interest of $4,000. On November 5, 2025, the Company issued 1,100,000 common shares that were converted from a convertible note with a principal amount of $10,000 and accrued interest of $1,000. On November 5, 2025, the Company issued 30,000,000 common shares as part of recently executed Settlement Agreement. Convertible Notes  On October 1, 2025, the Company issued a convertible note in the amount of $25,000. In connection with the convertible note, the Company issued 2,500,000 warrants with an exercise price of $0.01 and a three-year term. On October 14, 2025, the Company issued convertible notes in the amount of $30,000. In connection with the convertible notes, the Company issued 3,000,000 warrants with an exercise price of $0.01 and a three-year term. On October 15, 2025, the Company issued convertibles notes in the amount of $15,000. In connection with the convertible notes, the Company issued 1,500,000 warrants with an exercise price of $0.01 and a three-year term. On October 31, 2025, the Company issued convertibles notes in the amount of $20,000. In connection with the convertible notes, the Company issued 2,000,000 warrants with an exercise price of $0.01 and a three-year term.  Auctus Settlement Agreement On November 5, 2025, Xeriant and Auctus entered into a Settlement